The importance of protein binding for the in vitro-in vivo extrapolation (IVIVE)-example of ibuprofen, a highly protein-bound substance.

作者: H. Mielke , E. Di Consiglio , R. Kreutz , F. Partosch , E. Testai

DOI: 10.1007/S00204-016-1863-Z

关键词:

摘要: A physiologically based human kinetic model (PBHKM) was used to predict the in vivo ibuprofen dose leading same concentration–time profile as measured cultured hepatic cells (Truisi et al. Toxicol Lett 233(2):172–186, 2015). We parameterized PBHKM with data from an study. Tissue partition coefficients were calculated by algorithm and also derived experimental vitro for liver. The predicted plasma excellent agreement when liver coefficient (3.01) demonstrating values line findings obtained postmortem tissues. results less adequate on (11.1). doses necessary reach concentrations 3610 mg using best fitting a of 3.01 compared 2840 mg 11.1. found that this difference is possibly attributable between protein binding (99.9 %) (nearly zero) highly dependent binding. Hence, fraction freely diffusible tissue several times higher than vivo. In consequence, extrapolating toxicity, it important consider non-intended vitro/in differences concentration which may occur due low content medium.

参考文章(28)
Linda D. Ferrell, Imtiaz Alam, Nathan M. Bass, Vanishing bile duct syndrome temporally associated with ibuprofen use The American Journal of Gastroenterology. ,vol. 91, pp. 1626- 1630 ,(1996)
Finkler A, Lee Cy, Acute intoxication due to ibuprofen overdose. Archives of Pathology & Laboratory Medicine. ,vol. 110, pp. 747- 749 ,(1986)
P. Bellwon, G.L. Truisi, F.Y. Bois, A. Wilmes, T. Schmidt, C.C. Savary, C. Parmentier, P.G. Hewitt, O. Schmal, R. Josse, L. Richert, A. Guillouzo, S.O. Mueller, P. Jennings, E. Testai, W. Dekant, Kinetics and dynamics of cyclosporine A in three hepatic cell culture systems Toxicology in Vitro. ,vol. 30, pp. 62- 78 ,(2015) , 10.1016/J.TIV.2015.07.016
Nynke I. Kramer, Emma Di Consiglio, Bas J. Blaauboer, Emanuela Testai, Biokinetics in repeated-dosing in vitro drug toxicity studies Toxicology in Vitro. ,vol. 30, pp. 217- 224 ,(2015) , 10.1016/J.TIV.2015.09.005
Jos G. Bessems, George Loizou, Kannan Krishnan, Harvey J. Clewell, Camilla Bernasconi, Frederic Bois, Sandra Coecke, Eva-Maria Collnot, Walter Diembeck, Lucian Romeo Farcal, Liesbeth Geraets, Ursula Gundert-Remy, Nynke Kramer, Gabriele Küsters, Sofia B. Leite, Olavi R. Pelkonen, Klaus Schröder, Emanuela Testai, Iwona Wilk-Zasadna, José-Manuel Zaldívar-Comenges, PBTK modelling platforms and parameter estimation tools to enable animal-free risk assessment Regulatory Toxicology and Pharmacology. ,vol. 68, pp. 119- 139 ,(2014) , 10.1016/J.YRTPH.2013.11.008
Antonios Douros, Elisabeth Bronder, Frank Andersohn, Andreas Klimpel, Michael Thomae, Giselle Sarganas, Reinhold Kreutz, Edeltraut Garbe, Drug‐induced liver injury: results from the hospital‐based Berlin Case–Control Surveillance Study British Journal of Clinical Pharmacology. ,vol. 79, pp. 988- 999 ,(2015) , 10.1111/BCP.12565
Corwin Hansch, David Hoekman, Albert Leo, Litai Zhang, Peng Li, The expanding role of quantitative structure-activity relationships (QSAR) in toxicology Toxicology Letters. ,vol. 79, pp. 45- 53 ,(1995) , 10.1016/0378-4274(95)03356-P
Dennis A. Smith, Li Di, Edward H. Kerns, The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery Nature Reviews Drug Discovery. ,vol. 9, pp. 929- 939 ,(2010) , 10.1038/NRD3287
Germaine L. Truisi, Emma Di Consiglio, Céline Parmentier, Camille C. Savary, Giuliana Pomponio, Frederic Bois, Birthe Lauer, Rozenn Jossé, Philip G. Hewitt, Stefan O. Mueller, Lysiane Richert, André Guillouzo, Emanuela Testai, Understanding the biokinetics of ibuprofen after single and repeated treatments in rat and human in vitro liver cell systems Toxicology Letters. ,vol. 233, pp. 172- 186 ,(2015) , 10.1016/J.TOXLET.2015.01.006